Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-11 Purchase | 2024-04-15 08:53 am | Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2,353,000 | $8.5 | $20,000,500 | 5,360,858 (Indirect) | View |
| 2023-06-26 Sale | 2023-06-28 3:47 pm | Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner | 16 | $12.93 | $207 | 3,848,632 (Direct) | View |
| 2023-06-15 Sale | 2023-06-20 5:15 pm | Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner | 2,056 | $12.14 | $24,960 | 3,848,648 (Direct) | View |
| 2023-06-12 Sale | 2023-06-14 6:33 pm | Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner | 5,893 | $12.29 | $72,412 | 3,850,704 (Direct) | View |
| 2022-11-17 Purchase | 2022-11-21 6:26 pm | Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner | 400,000 | $12.5 | $5,000,000 | 3,856,597 (Direct) | View |
| 2022-11-17 Purchase | 2022-11-21 4:31 pm | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,389,500 | $12.5 | $42,368,750 | 426,302 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-17 Tax Withholding | 2024-04-19 4:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $10.34 | 39,893 (Direct) | View |
| 2024-04-11 Option Award | 2024-04-15 4:15 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,530,000 | $8.5 | 8,340,508 (Indirect) | View |
| 2024-03-04 Option Award | 2024-03-06 4:32 pm | N/A 2034-03-03 | Acrivon Therapeutics Inc. | ACRV | Palani Santhosh Director | 32,500 | $0 | 32,500 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:14 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 217 | $3.4 | 40,451 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:13 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations | 579 | $3.4 | 2,935,038 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:12 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 434 | $3.4 | 27,626 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 468 | $3.4 | 18,167 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:08 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 723 | $3.4 | 59,710 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:06 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO | 41,861 | $3.4 | 2,935,038 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:37 pm | N/A 2034-02-07 | Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director | 32,500 | $0 | 32,500 (Direct) | View |
| 2024-01-17 Tax Withholding | 2024-01-19 4:24 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 652 | $4.35 | 40,668 (Direct) | View |
| 2024-01-11 Option Award | 2024-01-16 4:45 pm | N/A 2034-01-10 | Acrivon Therapeutics Inc. | ACRV | Cuillerot Jean-Marie Chief Medical Officer | 99,300 | $0 | 99,300 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:43 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 735 | $5.08 | 41,320 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:42 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations | 1,900 | $5.08 | 2,977,478 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:42 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 1,470 | $5.08 | 28,060 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:41 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Medical Officer | 1,395 | $5.08 | 18,635 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:41 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 2,450 | $5.08 | 60,433 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:41 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO | 239,023 | $5.08 | 2,977,478 (Direct) | View |
| 2023-10-17 Tax Withholding | 2023-10-19 7:45 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 2,232 | $5.48 | 42,055 (Direct) | View |
| 2023-09-26 Option Award | 2023-09-28 7:17 pm | N/A 2033-09-25 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 15,434 | $0 | 55,863 (Direct) | View |
Ownership | 2023-09-28 7:13 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 0 | $0 | 161,715 (Direct) | View |
| 2023-08-21 Option Award | 2023-08-23 4:19 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO | 493,994 | $0 | 3,218,401 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-28 5:06 pm | N/A 2033-06-21 | Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director | 32,500 | $0 | 32,500 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-20 5:21 pm | N/A 2032-06-28 | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 9,500 | $0 | 212,649 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-20 5:21 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 9,500 | $3.63 | 212,649 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 4:15 pm | N/A 2031-01-13 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 9,225 | $0 | 159,498 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 4:15 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 9,225 | $1.04 | 159,498 (Direct) | View |
| 2023-05-31 Exercise | 2023-06-01 8:40 pm | N/A 2032-03-22 | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO | 33,605 | $0 | 2,877,492 (Direct) | View |
| 2023-05-31 Exercise | 2023-06-01 8:40 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO | 33,605 | $3.88 | 2,877,492 (Direct) | View |
| 2022-11-17 Conversion | 2022-11-21 6:26 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner | 11,980,570 | $0 | 3,856,597 (Direct) | View |
| 2022-11-17 Conversion | 2022-11-21 4:31 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 4,925,218 | $0 | 426,302 (Indirect) | View |
| 2022-11-17 Conversion | 2022-11-21 1:22 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 3,078,261 | $0 | 888,130 (Direct) | View |
Ownership | 2022-11-18 4:34 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 0 | $0 | 3,007,858 (Indirect) | View |
| 2022-11-14 Option Award | 2022-11-16 9:05 pm | N/A 2032-11-13 | Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director | 35,235 | $0 | 35,235 (Direct) | View |
| 2022-11-14 Option Award | 2022-11-16 7:33 pm | N/A 2032-11-13 | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 35,235 | $0 | 35,235 (Indirect) | View |